Regs & Legs

SUEZ – Ozonia^® Ozone Systems

Take control of your impurities testing

5 October 2018 | By PerkinElmer

The control of impurities plays a crucial role in Pharma QA/QC and can be divided in 3 main buckets: Organic, Inorganic and Residual Solvents.  On this webinar we are focusing on analytical techniques used for control of Inorganic impurities and Residual Solvents...

NIAID plan for in-depth tuberculosis research

27 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...

Pharma firms step up plans to beat Brexit supply chain disruption

26 September 2018 | By Mike Stones

The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...

Biosimilars market to increase to $61.47 billion

25 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed...

Cell therapy rejected for aggressive adult lymphoma on the NHS

24 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

A CAR-T immunotherapy for adults with an aggressive form of non-Hodgkin lymphoma has been provisionally rejected by the NHS...

FDA encourages appropriate prescribing of opioids

20 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

The FDA has updated its Opioid Analgesic REMS to ensure caregivers and patients use opioids effectively...

SPC manufacturing waiver is good news for Europe

19 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

An SPC manufacturing waiver should be extremely beneficial for Europe and will increase net sales of the EU pharmaceutical industry...

Expert view: Current trends in detection of falsified medicines

19 September 2018 | By Kathryn Lawson-Wood (PerkinElmer Inc.)

There is global public health concern over the falsification of pharmaceutical products and the extent to which widespread distribution of substandard drugs has developed...

Application Note: Analytical vs Preparative HPLC: what’s the difference?

18 September 2018 | By Gilson

The advent of High Performance Liquid Chromatography (HPLC) has revolutionised analytical chemistry, greatly enhancing not only the speed of column chromatography, but also the separation and identification capacity of analytes...

Drug prices increased twice as fast during shortages

18 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

A team of researchers have found that drugs increase in price twice as fast during shortages than if there were not supply and demand imbalances...

Understanding the complexities of global serialisation & traceability regulations

18 September 2018 | By Clarivate Analytics

In 2017 the WHO estimated that the counterfeit drug market represents around 10-15 per cent of the pharmaceutical market worldwide, with an estimated $200bn revenue per year. Worldwide there were 3,509 pharmaceutical crime incidents in 2017, which represents an 11% increase from 2016. Most falsified medicines that reach the market…

Expert view: Therapeutics trends and pharma technologies – in a state of flux

17 September 2018 | By Ajit Kanetkar (ACG)

The global pharmaceutical industry has been expanding steadily at varying rates of regional growth; the pace of growth being relatively slow in the developed, matured markets but rapid in developing nations...

Is cancer fundraising fuelling deceit?

14 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

Researchers questioned whether cancer crowdfunding elicits deception, especially when offering patients treatments with no scientific backing...

More than half of EU clinical trials do not comply with rules

14 September 2018 | By Iqra Farooq (European Pharmaceutical Review)

Researchers from the University of Oxford have identified that only 49.5 percent of clinical trials correctly report their results on time...